Research Topics
Species | K E MaloneSummaryAffiliation: Fred Hutchinson Cancer Research Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Mail Stop M4 B874, Seattle, WA 98109 1024, USA
Breast Cancer Res Treat 123:491-8. 2010..However, given the higher absolute CBC risk in mutation carriers, the potentially greater impact of adjuvant therapy in reducing CBC risk among mutation carriers should be considered when developing treatment plans for these patients...
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka
Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22908 0717, USA
Breast Cancer Res 13:R114. 2011..A subset of these SNPs, selected upon their main effects on contralateral breast cancer risk was further evaluated for interaction with treatment modalities and estrogen receptor (ER) status...
Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American womenBritton Trabert
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Fairview Ave N, Seattle, Washington 98109 1024, USA
Breast Cancer Res 9:R84. 2007..The involvement of vitamin D receptor (VDR), which is a key mediator in the vitamin D pathway, in breast cancer etiology has long been of interest...
Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young womenDanielle M Friedrichsen
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Breast Cancer Res 6:R629-35. 2004..However, the 1100delC mutation has only been investigated in a few population-based studies and none from North America...
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2Kathleen E Malone
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98006, USA
J Clin Oncol 28:2404-10. 2010..This study assessed the risk of subsequent contralateral breast cancer associated with carrying a BRCA1 or BRCA2 mutation...
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 yearsKathleen E Malone
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Cancer Res 66:8297-308. 2006....
Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancerKathleen E Malone
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Cancer Epidemiol Biomarkers Prev 20:2560-71. 2011..Inherited predisposition may be associated with distinctive breast cancer phenotypes and/or mortality. Past studies have had inconsistent results and little is known about the contributions of screening and treatment...
BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family historyK E Malone
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Wash 98109 1024, USA
JAMA 279:922-9. 1998..Thus, studies of women from the general population are needed to determine the BRCA1 mutation frequency in women perceived to be at high risk, and to develop profiles of those most likely to be carriers...
Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer riskKerryn W Reding
Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington 98109, USA
Am J Epidemiol 170:1241-9. 2009..1, 2.2) but not in never users (P(heterogeneity) = 0.02). Interpretation of these subgroup associations must await the results of similar studies conducted in other populations...
Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family historyS N Teraoka
Molecular Genetics Program, Virginia Mason Research Center, 1201 Ninth Avenue, Seattle, WA 98101-2795, USA
Cancer 92:479-87. 2001..CONCLUSIONS: ATM mutations, specifically missense mutations, are more common in breast carcinoma cases selected for first-degree family history and early age at diagnosis...
Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancerC I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
J Natl Cancer Inst 93:1008-13. 2001..Tamoxifen therapy reduces this risk, but it is unclear if this benefit exists for both estrogen receptor (ER)-positive and ER-negative contralateral tumors...
Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparationC C Ton
Divisions of Human Biology, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA
Breast Cancer Res Treat 125:879-83. 2011..These results indicate that a large fraction of decade-old FFPE samples, of diverse institutional origins and processing histories, can yield RNA suitable for gene expression profiling experiments...
Ovarian cancer risk and polymorphisms involved in estrogen catabolismSarah K Holt
Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, P O Box 19024 M4 C308, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 16:481-9. 2007..No association of ovarian cancer risk was observed with any of the other polymorphisms examined, either alone or in combination...
Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young womenNicola M Suter
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 12:127-35. 2003..In addition, these data suggest that AR repeat length may be partly responsible for the increased risk for early-onset breast cancer in women who use OCs, although these findings need replication in other populations...
Migraine in postmenopausal women and the risk of invasive breast cancerRobert W Mathes
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 C308, P O Box 19024, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 17:3116-22. 2008..Given the strong relationship between endogenous estrogen levels and breast cancer risk, migraine sufferers may experience a reduced risk of breast cancer...
Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer riskKerryn W Reding
University of Washington, Seattle, WA 98109, USA
Cancer Epidemiol Biomarkers Prev 18:1461-7. 2009....
Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinomaJ R Daling
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA
Cancer 92:720-9. 2001..Few studies have focused on premenopausal women or the correlation of body mass index (BMI) to tumor characteristics related to prognosis...
Case-control differences in the reliability of reporting a history of induced abortionM T Tang
Department of Epidemiology, School of Public Health, University of Washington, Seattle, USA
Am J Epidemiol 151:1139-43. 2000..9%, 95% confidence interval of the difference: -15, 14). The authors' data do not suggest that controls are more reluctant to report a history of induced abortion than are women with breast cancer...
Hair product use and the risk of breast cancer in young womenL S Cook
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Cancer Causes Control 10:551-9. 1999..This case-control study evaluated how detailed aspects of hair coloring and hair spray application by reproductive-age women may affect breast cancer risk...
Risk factors for triple-negative breast cancer in women under the age of 45 yearsJessica M Dolle
Fred Hutchinson Cancer Research Center, M4 C308 Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 18:1157-66. 2009....
The relation of reproductive factors to mortality from breast cancerJanet R Daling
Fred Hutchinson Cancer Research Center, Divisions of Public Health Sciences, Seattle, Washington 98109-1024, USA
Cancer Epidemiol Biomarkers Prev 11:235-41. 2002....
Reproductive factors, age at maximum height, and risk of three histologic types of breast cancerElisabeth F Beaber
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 C308, P O Box 19024, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 17:3427-34. 2008..5-0.9) but not lobular or ductal-lobular carcinoma. Further exploration of breast cancer risk by histology is merited to understand differences in the etiology of ductal, lobular, and ductal-lobular carcinoma...
The relationship between various measures of cigarette smoking and risk of breast cancer among older women 65-79 years of age (United States)Christopher I Li
Division of Public Health Sciences, Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Cancer Causes Control 16:975-85. 2005..A further understanding of the timing of smoking, and its interaction with other factors, may enhance our knowledge of whether and by what mechanisms smoking alters breast cancer risk...
Antidepressant use and breast cancer riskChloe Chien
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Breast Cancer Res Treat 95:131-40. 2006..However, human studies evaluating use of antidepressants in relation to breast cancer risk have yielded inconsistent results...
Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivorsCatherine M Alfano
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Psychooncology 15:985-1000. 2006..Future clinical trials and quality of life and symptom management intervention studies would benefit from accurate assessment of hormone-related symptoms with the five scales from the shortened BCPT checklist...
Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001Christopher I Li
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Epidemiology Program, Seattle, Washington, USA
Cancer 106:2104-12. 2006..Incidence rates of ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS) have been rising, but little is known about which patients will develop invasive breast cancer or what types of tumors these patients may develop...
Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal womenChristopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 18:2030-4. 2009..It extends the prior report in observing that this relationship holds for both premenopausal and postmenopausal women and is independent of exposure to common migraine triggers...
Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancerChristopher I Li
Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 C308, P O Box 19024, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 15:946-54. 2006....
Reproductive history and risk of three breast cancer subtypes defined by three biomarkersAmanda I Phipps
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M4 B402, Seattle, WA 98109 1024, USA
Cancer Causes Control 22:399-405. 2011..31-2.56). Neither parity nor age at first birth was associated with triple-negative breast cancer. In contrast to ER+ and ER-/PR-/HER2+ subtypes, reproductive history does not appear to be a risk factor for triple-negative breast cancer...
Family history of breast cancer in first-degree relatives and triple-negative breast cancer riskAmanda I Phipps
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M4 B402, PO Box 19024, Seattle, WA 98109 1024, USA
Breast Cancer Res Treat 126:671-8. 2011..Having a first-degree family history of breast cancer was associated with an increased risk of triple-negative breast cancer with a magnitude of association similar to that for the predominant ER+ subtype and ER-/PR-/HER2+ breast cancer...
Timing of menarche and first full-term birth in relation to breast cancer riskChristopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Am J Epidemiol 167:230-9. 2008..The authors conclude that the interval between age at menarche and age at first birth is associated with the risk of hormonally sensitive types of breast cancer, particularly among White women...
Relationship between diabetes and risk of second primary contralateral breast cancerChristopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 1024, USA
Breast Cancer Res Treat 125:545-51. 2011..This is the first study to report this relationship, but if confirmed efforts to insure that diabetic breast cancer survivors are carefully screened for second breast cancers may be warranted...
Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomasChristopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 17:43-50. 2008..Further studies focusing on the etiology of lobular carcinomas are needed...
Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancerRobert W Mathes
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 17:67-72. 2008..The few previous studies evaluating this association have been null but have been limited by small sample sizes, and none have evaluated risk by either histologic type or estrogen receptor/progesterone receptor status...
Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancerChristopher I Li
Divisions of Public Health Sciences and Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
J Clin Oncol 27:5312-8. 2009..We evaluated the relationships between obesity, alcohol consumption, and smoking on risk of second primary invasive contralateral breast cancer among breast cancer survivors...
Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal womenAmanda I Phipps
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 C308, P O Box 19024, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 17:2078-86. 2008..Given the expanding obesity epidemic, the widespread cessation of hormone therapy use, and the poor prognosis of triple-negative tumors, this novel finding merits confirmation...
Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancerAmanda I Phipps
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Cancer 113:1521-6. 2008..Reproductive factors may plausibly be differentially correlated with the risk of different breast cancer subtypes because these factors are presumed to impact exposure to endogenous sex hormones...
Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancerChristopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Cancer Res 69:6865-70. 2009..This is of clinical concern given the poorer prognosis of ER- compared with ER+ tumors...
Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001Christopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 C308, P O Box 19024, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 14:1008-11. 2005..These trends present important public health and clinical challenges...
Hormonal factors and breast tumor proliferation: do factors that affect cancer risk also affect tumor growth?Nina Oestreicher
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA
Breast Cancer Res Treat 85:133-42. 2004..We examined the association between hormone-related breast cancer risk factors and breast tumor proliferation, as reflected in two proliferation measures, Ki-67 and mitotic count...
A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older womenDenise M Boudreau
Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
Am J Epidemiol 159:308-17. 2004..Trivial changes in estimates were observed when health maintenance organization records alone were used as the gold standard. Self-reported use of antihypertensives and statins appears to be relatively accurate among older women...
Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 yearsJanet R Daling
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 12:1175-81. 2003....
Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of ageChristopher I Li
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, WA 98109, USA
Int J Cancer 107:647-51. 2003....
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 yearsChristopher I Li
Public Health Sciences Division, Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Cancer 98:1504-13. 2003....
Childbearing and survival after breast carcinoma in young womenBeth A Mueller
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, and Department of Epidemiology, University of Washington, Seattle, Washington, USA
Cancer 98:1131-40. 2003..The authors measured relative mortality among young patients with breast carcinoma with and without births occurring after diagnosis...
The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of ageChristopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 12:1061-6. 2003..These results are consistent with there being an underlying hormonal basis for the known association between alcohol use and breast cancer incidence...
Relationship between long durations and different regimens of hormone therapy and risk of breast cancerChristopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
JAMA 289:3254-63. 2003..Women using combined estrogen and progestin hormone replacement therapy (CHRT) have an increased risk of breast cancer; however, data on use for long durations and on risk associated with patterns of use are lacking...
Differences in breast cancer stage, treatment, and survival by race and ethnicityChristopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, MP 381, PO Box 19024, Seattle, WA 98109 1024, USA
Arch Intern Med 163:49-56. 2003..However, Asians and Pacific Islanders and Hispanic whites are heterogeneous populations, and few studies have evaluated breast cancer stage, treatments, and mortality rates for subgroups of these populations...
Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and olderChristopher I Li
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 11:601-7. 2002..Understanding the factors underlying these differences may provide further insight into breast cancer etiology in different populations...
Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinomaJanet R Daling
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Cancer 95:2455-64. 2002..However, the use of combined (estrogen and progestin) hormone replacement therapy (CHRT) also has increased during the last decade and may account in part for the increase in invasive lobular breast carcinoma...
Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998Christopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
J Clin Oncol 21:28-34. 2003..This is because hormone receptor status may reflect different etiologic pathways and is useful in predicting response to adjuvant therapy and prognosis...
Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States)Christopher I Li
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, 1100 Fairview Avenue North, M4 C308, 19024, Seattle, Washington 98109 1024, USA
Cancer Causes Control 17:695-703. 2006..To assess interactions between use of estrogen plus progestin hormone therapy (EPHT) and body mass index (BMI) in relation to risks of different types of breast cancer, based on histology and hormone receptor status...
Allergy and risk of breast cancer among young women (United States)Monique M Hedderson
Fred Hutchinson Center Research Program, Division of Public Health Sciences, Seattle, WA, USA
Cancer Causes Control 14:619-26. 2003..To investigate the relationship between allergy and risk of breast cancer in women 45 years of age and younger...
The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control studyDenise M Boudreau
Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
Cancer 100:2308-16. 2004..However, statins have been found to be carcinogenic in rodents and one clinical trial found an excess of breast carcinoma cases in the treatment group...
Effect of prediagnostic alcohol consumption on survival after breast cancer in young womenKerryn W Reding
Fred Hutchinson Cancer Research Center, M4 C308, Box 19024, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 17:1988-96. 2008..Alcohol consumption has been comprehensively investigated as an etiologic risk factor for breast cancer but has received little attention in terms of its effect on prognosis after breast cancer, particularly for young women...
Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancerL W M Loo
Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Genes Chromosomes Cancer 47:1049-66. 2008..LOH in chromosomal arms 8p and 5q was common in higher grade IDC tumors, whereas ILC and low-grade IDC grouped together by virtue of LOH in 16q...
Epidemiologic and molecular risk factors for contralateral breast cancer among young womenC I Li
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, 1100 Fairview Avenue North, MP 381, PO Box 19024, Seattle, WA 98109 1024, USA
Br J Cancer 89:513-8. 2003..Further observational studies are needed to confirm these findings and to evaluate whether testing for c-erbB-2 in this population may help identify those at high risk for CBC...
Case-control study of fetal microchimerism and breast cancerVijayakrishna K Gadi
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
PLoS ONE 3:e1706. 2008..We asked whether presence of FMc, routinely acquired during pregnancy, is a protective factor for breast cancer...
Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypesLenora W M Loo
Division of Human Biology, Division of Public Health Sciences, and Genomics Shared Resource, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Cancer Res 64:8541-9. 2004..These results indicate that array comparative genomic hybridization can identify significant differences in the genomic alterations between subtypes of breast cancer...
Psychometric evaluation of the Brief Cancer Impact Assessment among breast cancer survivorsCatherine M Alfano
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Oncology 70:190-202. 2006..CONCLUSION: Including the BCIA with measures of QOL, symptoms, and functioning will allow researchers to gain a more comprehensive assessment of the biopsychosocial IOC in survivors...
Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences StudyMichael S Simon
Division of Hematology and Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, MI 48201, USA
J Clin Oncol 24:2498-504. 2006..The purpose of this report is to update breast cancer risk estimates associated with a family history of breast cancer for white and AA women...
Reproductive factors and risk of breast carcinoma in a study of white and African-American womenGiske Ursin
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, USA
Cancer 101:353-62. 2004....
Breast cancers among very young premenopausal women (United States)Michelle D Althuis
National Cancer Institute, Rockville, MD, USA
Cancer Causes Control 14:151-60. 2003..To assess risk factors for breast cancer among very young compared to older premenopausal women...
Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences StudyRonald T Burkman
National Cancer Institute Surveillance, Epidemiology, and End Results Registry, Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, Michigan, USA
Fertil Steril 79:844-51. 2003..To determine the association between infertility drug use and invasive breast cancer in a population-based case-control study...
Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancerBrian L Strom
Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, 824 Blockley Hall, 423 Guardian Drive, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
Contraception 69:353-60. 2004..This study does not support an increased risk of breast cancer associated with the use of injectable or implantable progestin-only contraceptives in women aged 35 to 64...
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani
The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21205 2011, USA
Ann Intern Med 147:441-50. 2007..At least 7 models for estimating the probabilities of having a mutation are used widely in clinical and scientific activities; however, the merits and limitations of these models are not fully understood...
Racial differences in the familial aggregation of breast cancer and other female cancersMichael S Simon
Division of Haematology and Oncology, Barbara Ann Karmanos Cancer Institute, 4100 John R, 4221 Hudson, Weber Cancer Research Building, Detroit, M1 48201, USA
Breast Cancer Res Treat 89:227-35. 2005..17 (1.22-3.85). In conclusion, these racially distinct aggregation patterns may reflect different modes of inheritance and/or environmental factors that impact cancer risk...
Lifetime recreational exercise activity and breast cancer risk among black women and white womenLeslie Bernstein
Department of Preventive Medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA
J Natl Cancer Inst 97:1671-9. 2005....
Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of ageJulie A Britton
Division of Environmental Health Science, Mount Sinai School of Medicine, New York, NY 10029, USA
Am J Epidemiol 156:507-16. 2002..These findings only modestly support the hypothesis that hormonally related risk factors have differing relations with ER+PR+ versus ER-PR- tumors among younger women...
Alcohol exposure and breast cancer: results of the women's contraceptive and reproductive experiences studyJill A McDonald
National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health, 4770 Buford Highway Northeast, MS-K22, Atlanta, GA 30341-3724, USA
Cancer Epidemiol Biomarkers Prev 13:2106-16. 2004..Further work is needed to explain how alcohol exposure, sex hormones, and tumor receptor status interact...
Oral contraceptives and the risk of breast cancerPolly A Marchbanks
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, USA
N Engl J Med 346:2025-32. 2002..CONCLUSIONS: Among women from 35 to 64 years of age, current or former oral-contraceptive use was not associated with a significantly increased risk of breast cancer...
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational resultsPolly A Marchbanks
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Ann Epidemiol 12:213-21. 2002..5% and 78.6%, respectively, with lower rates for black women and older women. CONCLUSIONS: The methodologic details of this large collaboration may assist researchers conducting similar investigations...
Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States)Sandra A Norman
Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, 801 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
Cancer Causes Control 17:921-9. 2006..We studied the benefit of modern mammography screening in community settings, evaluating age-related differences in rates of late-stage breast cancer detection...
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE studyJonine L Bernstein
Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY, USA
Breast Cancer Res 6:R199-214. 2004..Three genes (ATM, BRCA1, and BRCA2) encode products that are essential for the normal cellular response to DSBs, but predispose to breast cancer when mutated...
Perinatal factors and mortality from breast cancerMaureen Sanderson
Division of Epidemiology, University of Texas Houston School of Public Health at Brownsville, 80 Fort Brown, Brownsville, TX 78520, USA
Cancer Epidemiol Biomarkers Prev 15:1984-7. 2006..1) and twin membership (HR, 2.5; 95% CI, 1.0-6.2). The protective effect of being born second or higher in the birth order against breast cancer mortality regardless of maternal age is striking and needs to be confirmed in future studies...
Protection of mammography screening against death from breast cancer in women aged 40-64 yearsSandra A Norman
Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, University of Pennsylvania, 801 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
Cancer Causes Control 18:909-18. 2007..This study assessed the efficacy of community-based screening mammography in protecting against breast cancer death, asking whether age differences in efficacy persisted in the 1990s...
Projecting individualized absolute invasive breast cancer risk in African American womenMitchell H Gail
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South Rm 8032, Bethesda, MD 20892 7244, USA
J Natl Cancer Inst 99:1782-92. 2007..We developed a model for projecting absolute risk of invasive breast cancer in African American women and compared its projections with those from the Breast Cancer Risk Assessment Tool...
Reproductive history and risk of second primary breast cancer: the WECARE studyJoan A Largent
Epidemiology Division, Department of Medicine, University of California, Irvine, Irvine, CA 92697 7555, USA
Cancer Epidemiol Biomarkers Prev 16:906-11. 2007..Women with an initial breast cancer diagnosis are at elevated risk of developing subsequent cancer in the contralateral breast. Studies of reproductive factors and contralateral breast cancer (CBC) have provided inconsistent results...
Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology StudyLisbeth Bertelsen
Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK 2100 Copenhagen Ø, Denmark
J Natl Cancer Inst 100:32-40. 2008..However, less is known about how long the risk is reduced and the impact of factors such as age and menopausal status...
Variation of breast cancer risk among BRCA1/2 carriersColin B Begg
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
JAMA 299:194-201. 2008..The risk of breast cancer in BRCA1 and BRCA2 mutation carriers has been examined in many studies, but relatively little attention has been paid to the degree to which the risk may vary among carriers...
Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study reportKathleen Meeske
Department of Preventive Medicine, Keck School of Medicine of University of Southern California, USC Norris Comprehensive Cancer Center, 1444 Eastlake Avenue, Room 4449, Los Angeles, CA 90033, USA
Qual Life Res 16:947-60. 2007....
Occupation and breast cancer in women 20-44 years of age (United States)Susan L Teitelbaum
Division of Environmental Health Science, Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
Cancer Causes Control 14:627-37. 2003..To examine the relation between breast cancer risk and job history among women 20-44 years of age who participated in a multi-center, population-based, case-control study...
Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study GroupJane C Figueiredo
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
J Clin Oncol 26:1411-8. 2008..To investigate whether oral contraceptive (OC) use and postmenopausal hormones (PMH) are associated with an increased risk of developing asynchronous bilateral breast cancer among women diagnosed with breast cancer younger than 55 years...
Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal womenSandra A Norman
Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
Cancer Causes Control 14:933-43. 2003..We examined breast cancer risk related to lifetime exposure to oral contraceptives (OCs) and hormone replacement therapy (HRT) in postmenopausal women...
Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: a prospective analysisCatherine M Alfano
Comprehensive Cancer Center and School of Public Health, The Ohio State University, Columbus, OH, USA
J Cancer Surviv 1:116-28. 2007..This prospective study investigated physical activity (PA), occurrence of physical symptoms, and HRQOL in a large, ethnically-diverse cohort of breast cancer survivors...
Risk of breast cancer associated with short-term use of oral contraceptivesSuzanne G Folger
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Cancer Causes Control 18:189-98. 2007..To estimate breast cancer risk associated with short-term (<6 months) oral contraceptive use, and explore variation in estimates by use characteristics and medical, menstrual, and reproductive history...
The association between oral contraceptive use and lobular and ductal breast cancer in young womenSarah J Nyante
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Int J Cancer 122:936-41. 2008..These results are similar to previous studies that report little difference in the effect of oral contraceptive use on breast cancer by histology...
Variants in the ATM gene associated with a reduced risk of contralateral breast cancerPatrick Concannon
Department of Biochemistry and Molecular Genetics and Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia 22908 0733, USA
Cancer Res 68:6486-91. 2008..1-0.6; c.6348-54T>C RR, 0.2; 95% CI, 0.1-0.8]. These data suggest that some alleles of ATM may exert an antineoplastic effect, perhaps by altering the activity of ATM as an initiator of DNA damage responses or a regulator of p53...
Hormone replacement therapy regimens and breast cancer risk(1)Linda K Weiss
Population Studies and Prevention Program, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA
Obstet Gynecol 100:1148-58. 2002..Progestin administered in an uninterrupted regimen may be a contributing factor. Risk dissipates once use is discontinued...
Validation of self-reported screening mammography histories among women with and without breast cancerSandra A Norman
Center for Clinical Epidemiology and Biostatistics and Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia 19104 6021, USA
Am J Epidemiol 158:264-71. 2003..Therefore, odds ratios will likely be biased toward the null, underestimating screening efficacy...
Research Grants
- Breast cancer and HRT: genetic susceptibility within th*Kathleen Malone; Fiscal Year: 2006..abstract_text> ..
- Adiposity Related Biomarkers and Breast Tumor SizeKathleen Malone; Fiscal Year: 2002..Findings from this study could begin to clarify a mechanism by which adiposity affects prognosis from breast cancer. ..
- FACTORS AFFECTING SURVIVAL OF YOUNG CANCER PATIENTSKathleen Malone; Fiscal Year: 2002....
- Breast cancer prognostic factors/pathobiologyKathleen Malone; Fiscal Year: 2009....
